2020 annual financial data
TransCode Therapeutics 2020 Operating margin
TransCode Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -726,604 USD and net income was -2,343,893 USD.
Operating cash flow was -492,971 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -726,604 USD
- Net income
- -2,343,893 USD
- Operating cash flow
- -492,971 USD